Functional interpretation of metabolomics data as a new method for predicting long-term side effects

Treatment of atopic dermatitis in infants

Seul Ji Lee, Sung Il Woo, Soo Hyun Ahn, Dong Kyu Lim, Ji Yeon Hong, Jeong Hill Park, Johan Lim, Mi Kyeong Kim, Sung Won Kwon

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Topical steroids are used for the treatment of primary atopic dermatitis (AD); however, their associated risk of serious complications is great due to the presence of vulnerable lesions in young children with AD. Topical calcineurin inhibitors (TCIs) are steroid-free, anti-inflammatory agents used for topical AD therapy. However, their use is prohibited in infants

Original languageEnglish (US)
Article number07408
JournalScientific Reports
Volume4
DOIs
StatePublished - Dec 10 2014

Fingerprint

Metabolomics
Atopic Dermatitis
Steroids
Anti-Inflammatory Agents
Therapeutics

ASJC Scopus subject areas

  • General
  • Medicine(all)

Cite this

Functional interpretation of metabolomics data as a new method for predicting long-term side effects : Treatment of atopic dermatitis in infants. / Lee, Seul Ji; Woo, Sung Il; Ahn, Soo Hyun; Lim, Dong Kyu; Hong, Ji Yeon; Park, Jeong Hill; Lim, Johan; Kim, Mi Kyeong; Kwon, Sung Won.

In: Scientific Reports, Vol. 4, 07408, 10.12.2014.

Research output: Contribution to journalArticle

Lee, Seul Ji ; Woo, Sung Il ; Ahn, Soo Hyun ; Lim, Dong Kyu ; Hong, Ji Yeon ; Park, Jeong Hill ; Lim, Johan ; Kim, Mi Kyeong ; Kwon, Sung Won. / Functional interpretation of metabolomics data as a new method for predicting long-term side effects : Treatment of atopic dermatitis in infants. In: Scientific Reports. 2014 ; Vol. 4.
@article{b074da6a03c1475781b6552b5760ae1d,
title = "Functional interpretation of metabolomics data as a new method for predicting long-term side effects: Treatment of atopic dermatitis in infants",
abstract = "Topical steroids are used for the treatment of primary atopic dermatitis (AD); however, their associated risk of serious complications is great due to the presence of vulnerable lesions in young children with AD. Topical calcineurin inhibitors (TCIs) are steroid-free, anti-inflammatory agents used for topical AD therapy. However, their use is prohibited in infants",
author = "Lee, {Seul Ji} and Woo, {Sung Il} and Ahn, {Soo Hyun} and Lim, {Dong Kyu} and Hong, {Ji Yeon} and Park, {Jeong Hill} and Johan Lim and Kim, {Mi Kyeong} and Kwon, {Sung Won}",
year = "2014",
month = "12",
day = "10",
doi = "10.1038/srep07408",
language = "English (US)",
volume = "4",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Functional interpretation of metabolomics data as a new method for predicting long-term side effects

T2 - Treatment of atopic dermatitis in infants

AU - Lee, Seul Ji

AU - Woo, Sung Il

AU - Ahn, Soo Hyun

AU - Lim, Dong Kyu

AU - Hong, Ji Yeon

AU - Park, Jeong Hill

AU - Lim, Johan

AU - Kim, Mi Kyeong

AU - Kwon, Sung Won

PY - 2014/12/10

Y1 - 2014/12/10

N2 - Topical steroids are used for the treatment of primary atopic dermatitis (AD); however, their associated risk of serious complications is great due to the presence of vulnerable lesions in young children with AD. Topical calcineurin inhibitors (TCIs) are steroid-free, anti-inflammatory agents used for topical AD therapy. However, their use is prohibited in infants

AB - Topical steroids are used for the treatment of primary atopic dermatitis (AD); however, their associated risk of serious complications is great due to the presence of vulnerable lesions in young children with AD. Topical calcineurin inhibitors (TCIs) are steroid-free, anti-inflammatory agents used for topical AD therapy. However, their use is prohibited in infants

UR - http://www.scopus.com/inward/record.url?scp=84942937983&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942937983&partnerID=8YFLogxK

U2 - 10.1038/srep07408

DO - 10.1038/srep07408

M3 - Article

VL - 4

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 07408

ER -